Skip to main content
SpringerLink
Log in

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

The immune response of CAF1 mice to various synthetic peptides (SP) related to the amino acid sequence (PDTRPAPGSTAPPAHGVTSA) of the tandem repeat of the MUC1 human breast mucin core peptide was evaluated. The most immunogenic preparations of the synthetic peptides were those conjugated to keyhole limpet hemocyanin (KLH) or clustered in a dendritic multiple antigenic peptide (MAP-4) configuration. The mice were immunized subcutaneously with synthetic peptides emulsified in RIBI adjuvant, employing various immunization protocols. Equivalently high IgG responses were induced using SP-KLH conjugates (GVTSAPDTRPAPGSTA-KLH) or an SP — MAP-4 chimeric configuration (SP1-6), which also included a universal malarial CST-3 T-helper epitope (SP1-6 = SAPDTRPAEKKIAKMEKASSVFNVVNS — MAP-4). These IgG antibodies bound both the appropriate MUC1 synthetic peptides and the cell surface expressed MUC1 mucin on murine mammary cells that had been transfected with the human MUC1 gene and a human breast cancer cell line that expresses cell-surface MUC1. A MAP-4 molecule, which included the entire 20-aminoacid sequence of the MUC1 tandem repeat (SP1-5 = PDTRPAPGSTAPPAHGVTSA—MAP-4) induced a poor IgG response. In contrast, all three types of molecule: SP-KLH, SP1-6 and SP1-5, were found to be good immunogens for the induction of specific delayedtype hypersensitivity (DTH) reactions measured using either synthetic peptides or MUC1-transfected cells. In addition, immunization with irradiated MUC1-transfected cells induced strong DTH reactions measured using synthetic peptides that expressed the PDTRP sequence, which has been shown to be, or to overlap, a T cell epitope in humans and a B cell epitope in mice. Finally, it was demonstrated that synthetic MUC1 peptide “vaccines” could be used both prophylactically and therapeutically to inhibit the growth of MUC1-transfected tumor cells and prolong the survival of tumor-bearing mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barnd DL, Lan MS, Metzgar RS, Finn OJ (1989) Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86: 7159

    PubMed  Google Scholar 

  2. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D (1987) Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47: 5476

    PubMed  Google Scholar 

  3. Codington JF, Frim DM (1983) Cell-surface macromolecular and morphological changes related to allotransplantability in the TA3 tumor. In: Manson LA (ed) Biomembranes, vol 2. Plenum, New York, p 207

    Google Scholar 

  4. Codington JF, Bhavanandan VP, Bloch KJ, Nikrui N, Ellard JV, Wang PS, Jeanloz RW (1984) Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patients. JNCI 73: 1029

    PubMed  Google Scholar 

  5. Fung PS, Longenecker BM (1991) Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-Ha). Cancer Res 51: 1170

    PubMed  Google Scholar 

  6. Fung PYS, Madej M, Koganty R, Longenecker BM (1990) Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res 50: 4308

    PubMed  Google Scholar 

  7. Friberg S Jr (1972) Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3: I. Transplantability, morphology and some physicochemical characteristics. JNCI 48: 1463

    PubMed  Google Scholar 

  8. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell J (1988) A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. Biol Chem 263: 12 820

    Google Scholar 

  9. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani E-N, Wilson D (1990) Molecular cloning and expression of the human tumor-associated polymorphic epithelial mucin, PEM. Biol Chem 265: 15 286

    Google Scholar 

  10. Hanisch F, Uhlenbruck G, Egge H, Peter-Katalinic J (1989) A B72.3 second-generation-monoclonal antibody (CC49) defines the mucincarried carbohydrate epitope Galβ(1–3)(NeuAcα(2–6))GalNAc. Biol Chem Hoppe-Seyler 370: 21

    PubMed  Google Scholar 

  11. Hareuveni M, Gautier C, Kieny M-P, Wreschner D, Chambon P, Lathe R (1990) Vaccination against tumor cells expressing breast cancer epithelial tumor antigen. Proc Natl Acad Sci USA 87: 9498

    PubMed  Google Scholar 

  12. Henningson CM, Selvaray S, MacLean GD, Suresh MR, Noujaim AA, Longenecker BM (1987) T cell recognition of tumorassociated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo. Cancer Immunol Immunother 25: 231

    PubMed  Google Scholar 

  13. Ho PC, Muteh DA, Winkel KD, Saul AJ, Jones GL, Doran TJ, Rzepczyk CM (1990) Identification of two promiscuous T-cell epitopes from tetanus toxin. Eur J Immunol 20: 477

    PubMed  Google Scholar 

  14. Hull SR, Bright A, Carraway KL, Abe M, Hayes DF, Kufe D (1989) Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun 1: 261

    PubMed  Google Scholar 

  15. Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S-I, Kim YS (1990) Sialosyl-Tn: a novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66: 1960

    PubMed  Google Scholar 

  16. Jentoff N (1990) Why are proteinsO-glycosylated? Trends Biochem Sci 15: 291

    PubMed  Google Scholar 

  17. Jerome KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IFC, Bast RC Jr, Finn OJ (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the malignant cells. Cancer Res 51: 2908

    PubMed  Google Scholar 

  18. Kahn M, Sugawara H, McGowan P, Okuno K, Nagoya S, Hellström KE, Hellström I, Greenberg P (1991) CD4+ cell clones specific for the human p97 melanoma-associated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen. J Immunol 146: 3235

    PubMed  Google Scholar 

  19. Kurosaka A, Kitagawa H, Fukui S, Numata Y, Nakada H, Funakoshi I, Kawasaki T, Ogawa T, Iijima H, Yamashina I (1988) A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAcα2-6GalNAc, in mucin-type glycoproteins. J Biol Chem 263: 8724

    PubMed  Google Scholar 

  20. Lalani E-N, Berdichevsky F, Boshell M, Shearer M, Wilson D, Stauss H, Gendler SJ, Taylor-Papadimitriou J (1991) Expression of the gene coding for a human mucin in mouse mammary tumour cells can affect their tumorigenicity. J Biol Chem 266: 15 420

    Google Scholar 

  21. Lan MS, Batra SK, Qi W-N, Metzgar RS, Hollingsworth MA (1990) Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 265: 15 294

    Google Scholar 

  22. Layton GT, Devine PL, Warren JA, Birrell G, Xing P-X, Ward BG, McKenzie IFC (1990) Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognize the ovarian carcinoma-associated sebaceous gland antigen. Tumor Biol 11: 274

    Google Scholar 

  23. MacLean G, Longenecker BM (1991) Novel synthetic immunother-apeutic vaccines for cancer: induction of hapten specific humoral immunity with reactivity with tumor cells. In: SBI '91 Biological Therapy of Cancer-VI Program and Abstracts. Society for Biological Therapy 1991 Annual Meeting, Pittsburgh, Pennsylvania

  24. MacLean GD, Bowen-Yacyshyn MB, Samuel J, Meikle A, Stuart G, Nation J, Poppema S, Jerry M, Koganty R, Wong T, Longenecker BM (1992) Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J Immunother 11: 292

    PubMed  Google Scholar 

  25. Miller SC, Hay ED, Codington JF (1977) Ultrastructural and histochemical differences in cell surface properties of strain-specific and non-strain specific TA3 adenocarcinoma cells. J Cell Biol 72: 511

    PubMed  Google Scholar 

  26. Parry G, Beck JC, Moss L, Bartley J, Ojakian GK (1990) Determination of apical membrane polarity in mammary epithelial cell cultures. The role of cell-cell, cell-substrate and membrane-cytoskeletal interaction. Exp Cell Res 188: 302

    PubMed  Google Scholar 

  27. Peat N, Gendler SJ, Lalani E-N, Duhig T, Taylor-Papadimitriou J (1992) Tissue specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res 52: 1954

    PubMed  Google Scholar 

  28. Samuel J, Noujaim AA, MacLean GD, Suresh MR, Longenecker BM (1990) Analysis of human tumor-associated Thomsen-Friedenreich antigen. Cancer Res 50: 4801

    PubMed  Google Scholar 

  29. Singhal A, Fohn M, Hakomori S (1991) Induction of α-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. Cancer Res 51: 1406

    PubMed  Google Scholar 

  30. Sinigaglia F, Guttinger M, Kilgus J, Doran DM, Martile H, Etlinger H, Trzeciak A, Gillessen D, Pink JRL (1988) A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 336: 778

    PubMed  Google Scholar 

  31. Springer GF (1984) T and Tn, general carcinoma autoantigens. Science 224: 1198

    PubMed  Google Scholar 

  32. Taylor-Papdimitriou J, Gendler SJ (1988) Molecular aspects of mucins. In: Hilgers J, Zotter S (eds) Cancer reviews. vol. 11–12. Munksgaard, Copenhagen, Denmark, p 11

    Google Scholar 

  33. Torben F, Orntoft NH, Langkilde NC (1990)O-Linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Int J Cancer 45: 666

    PubMed  Google Scholar 

  34. Wong RCK, Remold-O'Donnell E, Vercelli D, Saneho J, Terhorst C, Rosen F, Geha R, Chatila T (1990) Signal transduction via leukocyte antigen CD43 (sialophorin). Feedback regulation by protein kinase C. J Immunol 144: 1455

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, University of Alberta, T6G 2H7, Edmonton, Alberta, Canada

    Lei Ding, John Samuel & B. Michael Longenecker

  2. Imperial Cancer Research Fund, Lincoln's Inn Fields, P. O. Box 123, WC2A 3PX, London, UK

    El-Nasir Lalani & Joyce Taylor-Papadimitriou

  3. Biomira Inc., 9411 — 20 Avenue, T6N 1E5, Edmonton, Alberta, Canada

    Mark Reddish, Rao Koganty, Ting Wong & B. Michael Longenecker

  4. Cross Cancer Institute, 11560 University Avenue, T6G 1Z2, Edmonton, Alberta, Canada

    Mary Beth Yacyshyn, Alison Meikle & B. Michael Longenecker

  5. Department of Biology, Camrose Lutheran University College, T4V 2R3, Camrose, Alberta, Canada

    Peter Y. S. Fung

Authors
  1. Lei Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. El-Nasir Lalani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark Reddish
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rao Koganty
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ting Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John Samuel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mary Beth Yacyshyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alison Meikle
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Peter Y. S. Fung
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Joyce Taylor-Papadimitriou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. B. Michael Longenecker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ding, L., Lalani, EN., Reddish, M. et al. Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene. Cancer Immunol Immunother 36, 9–17 (1993). https://doi.org/10.1007/BF01789125

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01789125

Key words

Search

Navigation